human | Q5 |
P496 | ORCID iD | 0000-0002-2921-4067 |
P106 | occupation | researcher | Q1650915 |
Q92140002 | A phase II, randomized study of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study |
Q93002480 | Protective Effects of Angong Niuhuang Pill on Early Atherosclerosis in ApoE-/- Mice by Reducing the Inflammatory Response |
Search more.